Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	tRNA-4-demethylwyosine synthase activity	TYW1B TYW1	1.71e-05	2	83	2	GO:0102521
GeneOntologyMolecularFunction	FMN binding	TYW1B TYW1 NOS1	3.73e-05	16	83	3	GO:0010181
GeneOntologyMolecularFunction	histone H3K27 methyltransferase activity	EHMT2 EHMT1	2.53e-04	6	83	2	GO:0046976
GeneOntologyMolecularFunction	oxo-acid-lyase activity	TYW1B TYW1	3.54e-04	7	83	2	GO:0016833
GeneOntologyMolecularFunction	histone H3K9 monomethyltransferase activity	EHMT2 EHMT1	4.70e-04	8	83	2	GO:0140948
GeneOntologyMolecularFunction	pyrophosphatase activity	ERCC3 RAP2A RAP2B DDX17 IQCA1 APTX MACF1 GNAL RAP2C GTPBP10 DCP1A	6.88e-04	839	83	11	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ERCC3 RAP2A RAP2B DDX17 IQCA1 APTX MACF1 GNAL RAP2C GTPBP10 DCP1A	6.95e-04	840	83	11	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ERCC3 RAP2A RAP2B DDX17 IQCA1 APTX MACF1 GNAL RAP2C GTPBP10 DCP1A	6.95e-04	840	83	11	GO:0016818
GeneOntologyMolecularFunction	histone H3K9me2 methyltransferase activity	EHMT2 EHMT1	7.52e-04	10	83	2	GO:0140947
GeneOntologyMolecularFunction	histone H3K9 methyltransferase activity	EHMT2 EHMT1	1.29e-03	13	83	2	GO:0046974
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	HARS2 AEN ERCC3 DDX17 TYW1B RNASE9 APTX TYW1 POLR3A	1.42e-03	645	83	9	GO:0140640
GeneOntologyBiologicalProcess	Rap protein signal transduction	RAP2A RAP2B RAP2C	2.06e-05	14	81	3	GO:0032486
Domain	FLAVODOXIN_LIKE	TYW1B TYW1 NOS1	4.50e-06	8	82	3	PS50902
Domain	Flavodoxin/NO_synth	TYW1B TYW1 NOS1	4.50e-06	8	82	3	IPR008254
Domain	Flavdoxin-like	TYW1B TYW1 NOS1	4.50e-06	8	82	3	IPR001094
Domain	Flavodoxin_1	TYW1B TYW1 NOS1	4.50e-06	8	82	3	PF00258
Domain	Flavoprotein-like_dom	TYW1B TYW1 NOS1	9.57e-06	10	82	3	IPR029039
Domain	-	TYW1B TYW1 NOS1	9.57e-06	10	82	3	3.40.50.360
Domain	tRNA_wybutosine-synth	TYW1B TYW1	1.90e-05	2	82	2	IPR013917
Domain	Wyosine_form	TYW1B TYW1	1.90e-05	2	82	2	PF08608
Domain	IF5A_HYPUSINE	EIF5AL1 EIF5A	5.70e-05	3	82	2	PS00302
Domain	Transl_elong_IF5A_C	EIF5AL1 EIF5A	5.70e-05	3	82	2	IPR020189
Domain	Transl_elong_IF5A	EIF5AL1 EIF5A	5.70e-05	3	82	2	IPR001884
Domain	eIF-5a	EIF5AL1 EIF5A	5.70e-05	3	82	2	PF01287
Domain	Trans_elong_IF5A_hypusine_site	EIF5AL1 EIF5A	5.70e-05	3	82	2	IPR019769
Domain	eIF-5a	EIF5AL1 EIF5A	5.70e-05	3	82	2	SM01376
Domain	Actinin_actin-bd_CS	SYNE2 MACF1 UTRN	1.36e-04	23	82	3	IPR001589
Domain	Spectrin	SYNE2 MACF1 UTRN	1.36e-04	23	82	3	PF00435
Domain	ACTININ_2	SYNE2 MACF1 UTRN	1.36e-04	23	82	3	PS00020
Domain	ACTININ_1	SYNE2 MACF1 UTRN	1.36e-04	23	82	3	PS00019
Domain	CH	SYNE2 ASPM MACF1 UTRN	1.91e-04	65	82	4	SM00033
Domain	CH	SYNE2 ASPM MACF1 UTRN	2.54e-04	70	82	4	PF00307
Domain	-	SYNE2 ASPM MACF1 UTRN	2.68e-04	71	82	4	1.10.418.10
Domain	Spectrin_repeat	SYNE2 MACF1 UTRN	2.74e-04	29	82	3	IPR002017
Domain	CH	SYNE2 ASPM MACF1 UTRN	2.98e-04	73	82	4	PS50021
Domain	CH-domain	SYNE2 ASPM MACF1 UTRN	3.31e-04	75	82	4	IPR001715
Domain	Spectrin/alpha-actinin	SYNE2 MACF1 UTRN	3.69e-04	32	82	3	IPR018159
Domain	SPEC	SYNE2 MACF1 UTRN	3.69e-04	32	82	3	SM00150
Domain	PreSET	EHMT2 EHMT1	3.94e-04	7	82	2	SM00468
Domain	Pre-SET	EHMT2 EHMT1	3.94e-04	7	82	2	PF05033
Domain	Pre-SET_dom	EHMT2 EHMT1	3.94e-04	7	82	2	IPR007728
Domain	PRE_SET	EHMT2 EHMT1	3.94e-04	7	82	2	PS50867
Domain	RAS	RAP2A RAP2B RAP2C	4.82e-04	35	82	3	PS51421
Domain	Small_GTPase_Ras	RAP2A RAP2B RAP2C	5.69e-04	37	82	3	IPR020849
Domain	rSAM	TYW1B TYW1	6.72e-04	9	82	2	IPR007197
Domain	Radical_SAM	TYW1B TYW1	6.72e-04	9	82	2	PF04055
Domain	P-loop_NTPase	ERCC3 RAP2A RAP2B SAMD9 DDX17 IQCA1 ASPM GNAL RAP2C GTPBP10 MYO5C	1.17e-03	848	82	11	IPR027417
Domain	Translation_prot_SH3-like	EIF5AL1 EIF5A	2.48e-03	17	82	2	IPR008991
Domain	Rib_L2_dom2	EIF5AL1 EIF5A	2.78e-03	18	82	2	IPR014722
Domain	-	EIF5AL1 EIF5A	2.78e-03	18	82	2	2.30.30.30
Domain	Myosin-like_IQ_dom	ASPM MYO5C	3.10e-03	19	82	2	IPR027401
Domain	-	ASPM MYO5C	3.10e-03	19	82	2	4.10.270.10
Domain	-	ERCC3 RAP2A RAP2B SAMD9 DDX17 IQCA1 GNAL RAP2C GTPBP10	5.35e-03	746	82	9	3.40.50.300
Domain	IQ	IQCA1 ASPM MYO5C	5.44e-03	81	82	3	SM00015
Domain	NA-bd_OB-fold	EIF5AL1 EIF5A STN1	5.82e-03	83	82	3	IPR012340
Domain	LisH	RMND5A NPAT	6.68e-03	28	82	2	SM00667
Domain	LisH	RMND5A NPAT	6.68e-03	28	82	2	IPR006594
Domain	LISH	RMND5A NPAT	6.68e-03	28	82	2	PS50896
Domain	IQ_motif_EF-hand-BS	IQCA1 ASPM MYO5C	7.28e-03	90	82	3	IPR000048
Domain	IQ	IQCA1 ASPM MYO5C	7.97e-03	93	82	3	PS50096
Pubmed	Rap2, but not Rap1 GTPase is expressed in human red blood cells and is involved in vesiculation.	RAP2A RAP2B RAP2C	5.23e-08	4	83	3	16540189
Pubmed	Ubiquitylation by Rab40b/Cul5 regulates Rap2 localization and activity during cell migration.	RAP2A RAP2B RAP2C	1.31e-07	5	83	3	35293963
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	EXOC6 NAA35 SYNE2 ARHGEF12 PLEKHA7 PCM1 POLR3A	2.44e-06	251	83	7	29778605
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DNAJC13 RAP2B AP2A1 KCNB1 EHMT2 FAM120C SYNE2 EHMT1 ARHGEF12 MACF1 NOS1 PCM1	3.02e-06	963	83	12	28671696
Pubmed	Comparison of Human Eukaryotic Translation Initiation Factors 5A1 and 5AL1: Identification of Amino Acid Residues Important for EIF5A1 Lysine 50 Hypusination and Its Protein Stability.	EIF5AL1 EIF5A	5.63e-06	2	83	2	37047039
Pubmed	Evidence of a sex-dependent restrictive epigenome in schizophrenia.	EHMT2 EHMT1	5.63e-06	2	83	2	25935252
Pubmed	Prenyl group identification of rap2 proteins: a ras superfamily member other than ras that is farnesylated.	RAP2A RAP2B	5.63e-06	2	83	2	8424780
Pubmed	Targeting H3K9 methyltransferase G9a and its related molecule GLP as a potential therapeutic strategy for cancer.	EHMT2 EHMT1	5.63e-06	2	83	2	33283949
Pubmed	Discovery of a gene family critical to wyosine base formation in a subset of phenylalanine-specific transfer RNAs.	TYW1B TYW1	5.63e-06	2	83	2	16162496
Pubmed	Distinct roles for histone methyltransferases G9a and GLP in cancer germ-line antigen gene regulation in human cancer cells and murine embryonic stem cells.	EHMT2 EHMT1	5.63e-06	2	83	2	19531572
Pubmed	G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription.	EHMT2 EHMT1	5.63e-06	2	83	2	18818694
Pubmed	Polyamines and eIF5A Hypusination Modulate Mitochondrial Respiration and Macrophage Activation.	EIF5AL1 EIF5A	5.63e-06	2	83	2	31130465
Pubmed	The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules.	EHMT2 EHMT1	5.63e-06	2	83	2	18264113
Pubmed	A post-translational modification switch controls coactivator function of histone methyltransferases G9a and GLP.	EHMT2 EHMT1	5.63e-06	2	83	2	28615290
Pubmed	Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.	EHMT2 EHMT1	5.63e-06	2	83	2	31775874
Pubmed	Independent roles of eIF5A and polyamines in cell proliferation.	EIF5AL1 EIF5A	5.63e-06	2	83	2	15377278
Pubmed	Increased H3K9 methylation and impaired expression of Protocadherins are associated with the cognitive dysfunctions of the Kleefstra syndrome.	EHMT2 EHMT1	5.63e-06	2	83	2	29554304
Pubmed	Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma.	EHMT2 EHMT1	5.63e-06	2	83	2	37894922
Pubmed	Sequence determination and cDNA cloning of eukaryotic initiation factor 4D, the hypusine-containing protein.	EIF5AL1 EIF5A	5.63e-06	2	83	2	2492279
Pubmed	The N-terminal region of eukaryotic translation initiation factor 5A signals to nuclear localization of the protein.	EIF5AL1 EIF5A	5.63e-06	2	83	2	17707773
Pubmed	Proteomic analysis of ubiquitin-proteasome effects: insight into the function of eukaryotic initiation factor 5A.	EIF5AL1 EIF5A	5.63e-06	2	83	2	12894223
Pubmed	Recognition of H3K9 methylation by GLP is required for efficient establishment of H3K9 methylation, rapid target gene repression, and mouse viability.	EHMT2 EHMT1	5.63e-06	2	83	2	25637356
Pubmed	Inhibition of euchromatic histone methyltransferase 1 and 2 sensitizes chronic myeloid leukemia cells to interferon treatment.	EHMT2 EHMT1	5.63e-06	2	83	2	25079219
Pubmed	G9a/GLP Complex Maintains Imprinted DNA Methylation in Embryonic Stem Cells.	EHMT2 EHMT1	5.63e-06	2	83	2	27052169
Pubmed	The histone H3 lysine 9 methyltransferase G9a/GLP complex activity is required for long-term consolidation of spatial memory in mice.	EHMT2 EHMT1	5.63e-06	2	83	2	33609736
Pubmed	Targeted inhibition of eIF5Ahpu suppresses tumor growth and polarization of M2-like tumor-associated macrophages in oral cancer.	EIF5AL1 EIF5A	5.63e-06	2	83	2	37653021
Pubmed	Identification and biochemical characterization of Rap2C, a new member of the Rap family of small GTP-binding proteins.	RAP2B RAP2C	5.63e-06	2	83	2	16213650
Pubmed	Context-Dependent Requirement of Euchromatic Histone Methyltransferase Activity during Reprogramming to Pluripotency.	EHMT2 EHMT1	5.63e-06	2	83	2	32976761
Pubmed	Identification of a new member of the human eIF-5A gene family.	EIF5AL1 EIF5A	5.63e-06	2	83	2	7622067
Pubmed	Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation.	EIF5AL1 EIF5A	5.63e-06	2	83	2	8253832
Pubmed	Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9.	EHMT2 EHMT1	5.63e-06	2	83	2	15774718
Pubmed	Heterodimerization of H3K9 histone methyltransferases G9a and GLP activates methyl reading and writing capabilities.	EHMT2 EHMT1	5.63e-06	2	83	2	34619147
Pubmed	Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.	EHMT2 EHMT1	5.63e-06	2	83	2	25365549
Pubmed	EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.	EHMT2 EHMT1	5.63e-06	2	83	2	26320100
Pubmed	Eukaryotic initiation factor 4D. Purification from human red blood cells and the sequence of amino acids around its single hypusine residue.	EIF5AL1 EIF5A	5.63e-06	2	83	2	3095320
Pubmed	EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms.	EHMT2 EHMT1	5.63e-06	2	83	2	34954891
Pubmed	GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.	EHMT2 EHMT1	5.63e-06	2	83	2	29855824
Pubmed	Exosomal EIF5A derived from Lewis lung carcinoma induced adipocyte wasting in cancer cachexia.	EIF5AL1 EIF5A	5.63e-06	2	83	2	37743008
Pubmed	Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A).	EIF5AL1 EIF5A	5.63e-06	2	83	2	11742107
Pubmed	The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.	EIF5AL1 EIF5A	5.63e-06	2	83	2	20501948
Pubmed	Rap2A links intestinal cell polarity to brush border formation.	RAP2A RAP2B RAP2C	5.84e-06	15	83	3	22797597
Pubmed	Role of TIF1alpha as a modulator of embryonic transcription in the mouse zygote.	EIF5AL1 HNF1B EIF5A	7.18e-06	16	83	3	16880268
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	DNAJC13 EHMT2 TET1 UTRN PCM1 PHF21A DCP1A NPAT	7.31e-06	418	83	8	34709266
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	ARHGEF12 MACF1 PDCL UTRN PCM1 DCP1A	1.13e-05	209	83	6	36779422
Pubmed	Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error.	GLE1 PLPBP PHF21A FILIP1L	1.16e-05	58	83	4	24144296
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	FAM120C ARHGEF12 DOCK6 UTRN PCM1	1.28e-05	125	83	5	29467281
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	EXOC6 DNAJC13 ERCC3 DDX17 NUP155 AP2A1 GLE1 ASPM MACF1 GTPBP10	1.34e-05	759	83	10	35915203
Pubmed	Deoxyhypusine synthase mutations alter the post-translational modification of eukaryotic initiation factor 5A resulting in impaired human and mouse neural homeostasis.	EIF5AL1 EIF5A	1.69e-05	3	83	2	37333770
Pubmed	FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.	EHMT2 EHMT1	1.69e-05	3	83	2	29259012
Pubmed	Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation.	EIF5AL1 EIF5A	1.69e-05	3	83	2	36893894
Pubmed	Maintenance of gene silencing by the coordinate action of the H3K9 methyltransferase G9a/KMT1C and the H3K4 demethylase Jarid1a/KDM5A.	EHMT2 EHMT1	1.69e-05	3	83	2	23112189
Pubmed	Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane.	UTRN NOS1	1.69e-05	3	83	2	22003386
Pubmed	Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression.	EIF5AL1 EIF5A	1.69e-05	3	83	2	11161802
Pubmed	Functional analysis of histone methyltransferase g9a in B and T lymphocytes.	EHMT2 EHMT1	1.69e-05	3	83	2	18566414
Pubmed	Essential role of eIF5A-1 and deoxyhypusine synthase in mouse embryonic development.	EIF5AL1 EIF5A	1.69e-05	3	83	2	21850436
Pubmed	New K50R mutant mouse models reveal impaired hypusination of eif5a2 with alterations in cell metabolite landscape.	EIF5AL1 EIF5A	1.69e-05	3	83	2	36848144
Pubmed	Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta.	SLC22A6 HNF1B	1.69e-05	3	83	2	18029548
Pubmed	Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.	EIF5AL1 EIF5A	1.69e-05	3	83	2	16519677
Pubmed	Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity.	EHMT2 EHMT1	1.69e-05	3	83	2	27588951
Pubmed	LSH and G9a/GLP complex are required for developmentally programmed DNA methylation.	EHMT2 EHMT1	1.69e-05	3	83	2	21149390
Pubmed	The alpha-syntrophin PH and PDZ domains scaffold acetylcholine receptors, utrophin, and neuronal nitric oxide synthase at the neuromuscular junction.	UTRN NOS1	1.69e-05	3	83	2	20720107
Pubmed	Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the 'effector' region.	RAP2A RAP2B	1.69e-05	3	83	2	3045729
Pubmed	Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.	UTRN NOS1	1.69e-05	3	83	2	20483958
Pubmed	Klf5 down-regulation induces vascular senescence through eIF5a depletion and mitochondrial fission.	EIF5AL1 EIF5A	1.69e-05	3	83	2	32817651
Pubmed	The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy.	EHMT2 EHMT1	1.69e-05	3	83	2	27893464
Pubmed	Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex.	EHMT2 EHMT1	1.69e-05	3	83	2	20005824
Pubmed	The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing.	EHMT2 EHMT1	1.69e-05	3	83	2	24389103
Pubmed	The role of polyamines in supporting growth of mammalian cells is mediated through their requirement for translation initiation and elongation.	EIF5AL1 EIF5A	1.69e-05	3	83	2	20181941
Pubmed	Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration.	EHMT2 EHMT1	1.69e-05	3	83	2	29860315
Pubmed	Evidences of a role for eukaryotic translation initiation factor 5A (eIF5A) in mouse embryogenesis and cell differentiation.	EIF5AL1 EIF5A	1.69e-05	3	83	2	20458750
Pubmed	Neuronal nitric oxide synthase localizes to utrophin expressing intercalated discs and stabilizes their structural integrity.	UTRN NOS1	1.69e-05	3	83	2	26483274
Pubmed	Subcellular localization of the hypusine-containing eukaryotic initiation factor 5A by immunofluorescent staining and green fluorescent protein tagging.	EIF5AL1 EIF5A	1.69e-05	3	83	2	12210765
Pubmed	Rap2 function requires palmitoylation and recycling endosome localization.	RAP2A RAP2B RAP2C	1.69e-05	21	83	3	19061864
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	DNAJC13 ZFYVE27 NUP155 TYW1B GLE1 SYNE2 TYW1 DOCK6	2.80e-05	504	83	8	34432599
Pubmed	Keap1 moderates the transcription of virus induced genes through G9a-GLP and NFκB p50 recruitment.	EHMT2 EHMT1	3.37e-05	4	83	2	35751391
Pubmed	Identification and characterization of potential effector molecules of the Ras-related GTPase Rap2.	RAP2A RAP2B	3.37e-05	4	83	2	10085114
Pubmed	Genetic variants in epigenetic genes and breast cancer risk.	EHMT2 EHMT1	3.37e-05	4	83	2	16501248
Pubmed	Structural and functional analysis of mRNA export regulation by the nuclear pore complex.	NUP155 GLE1	3.37e-05	4	83	2	29899397
Pubmed	The genomic structure encoding human initiation factor eIF-5A.	EIF5AL1 EIF5A	3.37e-05	4	83	2	7545941
Pubmed	The eukaryotic cofactor for the human immunodeficiency virus type 1 (HIV-1) rev protein, eIF-5A, maps to chromosome 17p12-p13: three eIF-5A pseudogenes map to 10q23.3, 17q25, and 19q13.2.	EIF5AL1 EIF5A	3.37e-05	4	83	2	7759117
Pubmed	Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase C epsilon.	RAP2A RAP2B	3.37e-05	4	83	2	12444546
Pubmed	The zinc finger proteins ZNF644 and WIZ regulate the G9a/GLP complex for gene repression.	EHMT2 EHMT1	3.37e-05	4	83	2	25789554
Pubmed	G9a and Glp methylate lysine 373 in the tumor suppressor p53.	EHMT2 EHMT1	3.37e-05	4	83	2	20118233
Pubmed	The mRNA export factor human Gle1 interacts with the nuclear pore complex protein Nup155.	NUP155 GLE1	3.37e-05	4	83	2	14645504
Pubmed	MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a.	EHMT2 EHMT1	3.37e-05	4	83	2	22086334
Pubmed	A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis.	EHMT2 EHMT1	3.37e-05	4	83	2	22430489
Pubmed	Ribonucleome analysis identified enzyme genes responsible for wybutosine synthesis.	TYW1B TYW1	3.37e-05	4	83	2	17150819
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	HARS2 ERCC3 RAP2B EHMT2 FAM120C APTX EHMT1 ARHGEF12 MACF1 RAP2C PLEKHA7 GTPBP10 UTRN	5.27e-05	1497	83	13	31527615
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AEN TYW1B TET1 FRMPD1 MACF1 TYW1 RAP2C PLEKHA7 UTRN DCP1A NPAT	5.33e-05	1084	83	11	11544199
Pubmed	Zinc finger protein Wiz links G9a/GLP histone methyltransferases to the co-repressor molecule CtBP.	EHMT2 EHMT1	5.60e-05	5	83	2	16702210
Pubmed	Biological Relevance and Therapeutic Potential of the Hypusine Modification System.	EIF5AL1 EIF5A	5.60e-05	5	83	2	26037925
Pubmed	PRC2 and EHMT1 regulate H3K27me2 and H3K27me3 establishment across the zygote genome.	EHMT2 EHMT1	5.60e-05	5	83	2	33311485
Pubmed	Automethylation of G9a and its implication in wider substrate specificity and HP1 binding.	EHMT2 EHMT1	5.60e-05	5	83	2	17962312
Pubmed	Stable G protein-effector complexes in striatal neurons: mechanism of assembly and role in neurotransmitter signaling.	GNAL PDCL	5.60e-05	5	83	2	26613416
Pubmed	SPOP mutation induces DNA methylation via stabilizing GLP/G9a.	EHMT2 EHMT1	5.60e-05	5	83	2	34588438
Pubmed	A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9.	EHMT2 EHMT1	5.60e-05	5	83	2	19010785
Pubmed	G9a regulates temporal preimplantation developmental program and lineage segregation in blastocyst.	EHMT2 EHMT1	5.60e-05	5	83	2	29745895
Pubmed	Dp71 gene disruption alters the composition of the dystrophin-associated protein complex and neuronal nitric oxide synthase expression in the hypothalamic supraoptic and paraventricular nuclei.	UTRN NOS1	5.60e-05	5	83	2	22493004
Pubmed	Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice.	EIF5AL1 EIF5A	5.60e-05	5	83	2	34688659
Pubmed	Localisation of a dystrophin-related autosomal gene to 6q24 in man, and to mouse chromosome 10 in the region of the dystrophia muscularis (dy) locus.	MDM1 UTRN	8.39e-05	6	83	2	2203673
Interaction	RCOR1 interactions	HNF1B DNAJC13 EHMT2 TET1 EHMT1 UTRN PCM1 PHF21A STN1 DCP1A NPAT	5.01e-06	494	82	11	int:RCOR1
Interaction	TRIM52 interactions	ASPM YY1AP1 WDR76 STN1 POLR3A MYO5C	1.71e-05	133	82	6	int:TRIM52
GeneFamily	RAS type GTPase family	RAP2A RAP2B RAP2C	6.59e-05	31	46	3	389
GeneFamily	Dynein regulatory complex	TCTE1 IQCA1	3.43e-04	11	46	2	981
GeneFamily	Nucleoporins	NUP155 GLE1	2.99e-03	32	46	2	1051
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	EHMT2 EHMT1	3.37e-03	34	46	2	487
GeneFamily	PDZ domain containing	FRMPD1 ARHGEF12 NOS1	6.79e-03	152	46	3	1220
GeneFamily	Ubiquitin specific peptidases	USP13 USP29	8.94e-03	56	46	2	366
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	DNAJC13 SYNE2 TET1 ASPM PDCL UTRN	2.53e-05	150	82	6	gudmap_developingGonad_e12.5_epididymis_k5_500
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HNF1B IQCA1 SYNE2 PLEKHA7 UTRN MYO5C	1.38e-06	187	83	6	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	COVID-19-kidney\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC22A6 HNF1B SUGCT SYNE2 PLEKHA7 SLC3A1	1.38e-06	187	83	6	d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EIF5AL1 SAMD9 DDX17 SYNE2 MACF1 PCM1	1.92e-06	198	83	6	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 DDX17 SYNE2 MACF1 UTRN PCM1	2.03e-06	200	83	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	SAMD9 DDX17 SYNE2 EIF5A MACF1 UTRN	2.03e-06	200	83	6	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EXOC6 SYNE2 ARHGEF12 MACF1 DOCK6 UTRN	2.03e-06	200	83	6	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EXOC6 SYNE2 APLP1 DOCK6 AKR1B1 FILIP1L	2.03e-06	200	83	6	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	facs-Skin-Anagen-3m-Epithelial-inner_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNB1 USP29 LCA5L APLP1 FGF18	1.28e-05	161	83	5	8d2987271da52fd8353557ac6faa4f7a4be0ed2a
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	DDX17 ZFYVE27 SYNE2 MACF1 UTRN	1.32e-05	162	83	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC22A6 HNF1B SUGCT PLPBP SLC3A1	1.44e-05	165	83	5	906321cb5f299d77436fb5540fd8c52d7532beca
ToppCell	facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC22A6 HNF1B SUGCT PLPBP SLC3A1	1.44e-05	165	83	5	02a09d0918b103aca21c36b42c5a8a8ebad8686c
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	ERCC3 EHMT2 SYNE2 PDCL NPAT	1.61e-05	169	83	5	bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	USP13 INPP5D SYNE2 MACF1 DOCK6	2.19e-05	180	83	5	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC22A6 HNF1B SUGCT SYNE2 SLC3A1	2.19e-05	180	83	5	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HNF1B SUGCT SYNE2 PLEKHA7 SLC3A1	2.37e-05	183	83	5	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP MYO5C	2.69e-05	188	83	5	bc0b9ba8ae88e8a89e98b446584ed39606e4229e
ToppCell	droplet-Lung-1m-Epithelial-airway_epithelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP MYO5C	2.69e-05	188	83	5	50994e304c719f2f3c3232e48141e2dd15c96612
ToppCell	droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP MYO5C	2.69e-05	188	83	5	a7b7ba56603a8a50869b41902aed6a9ab1c5c021
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A6 SUGCT SYNE2 PLEKHA7 SLC3A1	2.90e-05	191	83	5	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A6 SUGCT SYNE2 PLEKHA7 SLC3A1	2.90e-05	191	83	5	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HNF1B KCNB1 IQCA1 SYNE2 SLC3A1	3.13e-05	194	83	5	8ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NAA35 SYNE2 MACF1 IDI1 UTRN	3.29e-05	196	83	5	ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX17 SYNE2 MACF1 UTRN PCM1	3.37e-05	197	83	5	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	distal-Endothelial-Bronchial_Vessel_2-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZFYVE27 INPP5D ARHGEF12 MYO5C FILIP1L	3.37e-05	197	83	5	9fcfbfbe78e8fe90c76eb37a58ed9dc8ece652a1
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	IQCA1 SYNE2 PLEKHA7 UTRN MYO5C	3.37e-05	197	83	5	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX17 SYNE2 MACF1 UTRN PCM1	3.53e-05	199	83	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SYNE2 ARHGEF12 MACF1 DOCK6 DISP1	3.62e-05	200	83	5	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SYNE2 ARHGEF12 MACF1 DOCK6 UTRN	3.62e-05	200	83	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SYNE2 ARHGEF12 MACF1 DOCK6 DISP1	3.62e-05	200	83	5	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SYNE2 ARHGEF12 MACF1 DOCK6 DISP1	3.62e-05	200	83	5	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EXOC6 SYNE2 DOCK6 AKR1B1 FILIP1L	3.62e-05	200	83	5	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SYNE2 ARHGEF12 MACF1 MYCBPAP DISP1	3.62e-05	200	83	5	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	EXOC6 SYNE2 APLP1 AKR1B1 FILIP1L	3.62e-05	200	83	5	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCell	mild-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 SYNE2 MACF1 GNAL UTRN	3.62e-05	200	83	5	a11fb1d7e124c352eb73fea0e0ec0fed577c97f7
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SAMD9 SYNE2 ARHGEF12 MACF1 UTRN	3.62e-05	200	83	5	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SYNE2 ARHGEF12 MACF1 DOCK6 DISP1	3.62e-05	200	83	5	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Cadm2+,_not_selective)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	HNF1B IQCA1 CCDC63	7.08e-05	43	83	3	7027858b46c0aabec290ed3888201a1b39e10552
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Cadm2+,_not_selective)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	HNF1B IQCA1 CCDC63	7.08e-05	43	83	3	0282410243ba125ec13fd6af737ddf952e493280
ToppCell	Control-Lymphoid_T/NK-NK_activated\|Control / Disease group, lineage and cell class	SYNE2 USP29 MACF1 GNAL	7.28e-05	119	83	4	a258d91ac90d4174b6f203d7f96ba6e57c6003e7
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCTE1 FRMPD1 FGF18 FILIP1L	9.08e-05	126	83	4	3539a8fdbb52d191f36dce68c38798ad4d2b491a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXOC6 INPP5D GNAL WDR76	1.33e-04	139	83	4	b07929348ec9ad95d7bce33a7deac0938227b19f
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAVER2 CASP2 GNAL UTRN	2.02e-04	155	83	4	d10cf5e922dbd3ca46660404da5aca43f181fc19
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	INPP5D SYNE2 EHMT1 THSD7B	2.07e-04	156	83	4	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TCTE1 FRMPD1 FGF18	2.55e-04	66	83	3	88afd3ab91774ce01ff4277395b7b59dbb23200a
ToppCell	Ciliated_cells-A-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	IQCA1 CCDC78 STOX1 MYCBPAP	2.87e-04	170	83	4	3d3a03979014df3a05c49be18010c6b94d786707
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SYNE2 MACF1 UTRN PCM1	2.93e-04	171	83	4	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC22A6 HNF1B SUGCT SLC3A1	2.93e-04	171	83	4	48fc4eca18b102b5ec5050f758281292ee8e10c6
ToppCell	droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC22A6 HNF1B SUGCT SLC3A1	2.93e-04	171	83	4	05fcc72df50a380a913821b5781d9621df37d328
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	USP13 CCDC78 LCA5L MYCBPAP	2.93e-04	171	83	4	52aec5f6677fe2f7a36fb5b18117a4cffaeff58f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE2 ASPM PDCL DOCK6	3.00e-04	172	83	4	eee45759284baa3ed77da6a5fbcc4f8f6c553106
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EIF5AL1 SAMD9 SYNE2 PLEKHA7	3.20e-04	175	83	4	cc2428150987911d0d382e8177918724aa69f85c
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MDM1 CCDC78 CASP2 DCP1A	3.27e-04	176	83	4	1510cdfcfb46ce1196a1220c07fb5f3986c81b78
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EIF5AL1 SAMD9 SYNE2 PLEKHA7	3.27e-04	176	83	4	003076f1a983409ddf31b9c19e61c1facdd72566
ToppCell	facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	3.34e-04	177	83	4	3cfde67b93f3986312f5e74e42504214d966e7dc
ToppCell	facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	3.34e-04	177	83	4	12a52a12a87a31e501ced611f46a90d172ca7e35
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE2 UTRN PCM1 FILIP1L	3.41e-04	178	83	4	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCTE1 IQCA1 CCDC78 MYCBPAP	3.56e-04	180	83	4	cf6e9f757afeb342c5023f6e6152a1b4d0d164b4
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IVL TCTE1 RAVER2 APLP1	3.56e-04	180	83	4	35c73670da90cb6924e822a2426d13a675685f09
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IQCA1 ASPM ANKRD30B DISP1	3.63e-04	181	83	4	3dcb74b28f93be35ddf4de1937f7e30b25e11927
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A6 SUGCT SYNE2 SLC3A1	3.63e-04	181	83	4	9542c19edc9bd2cba68c01c2a8407705398e3011
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MACF1 DOCK6 UTRN FILIP1L	3.63e-04	181	83	4	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4\|TCGA-Endometrium / Sample_Type by Project: Shred V9	TCTE1 CCDC78 LCA5L MYCBPAP	3.63e-04	181	83	4	51d91b923920463245e95d65c6a5197e21d34d73
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A6 SUGCT SYNE2 SLC3A1	3.63e-04	181	83	4	8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IQCA1 ASPM ANKRD30B DISP1	3.63e-04	181	83	4	7679a5980011d6dfb1aaca7abf678c29b6f819bb
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EIF5AL1 EIF5A ASPM MOSPD1	3.79e-04	183	83	4	d4aa21ba4f6f92e25ecff80b7399bca31527fd7e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD1 GNAL THSD7B NOS1	3.79e-04	183	83	4	5a541a7f6c3514be8a13e988185dfe388c874f8b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYNE2 PLEKHA7 UTRN MYO5C	3.87e-04	184	83	4	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EXOC6 INPP5D THSD7B NOS1	3.87e-04	184	83	4	a809b0fa52df8a159f60f87eefcef61220af5e34
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 UTRN PCM1 FILIP1L	3.87e-04	184	83	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	EXOC6 DOCK6 NOS1 FGF18	3.87e-04	184	83	4	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	COVID-19-kidney-Mito-rich_PCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC22A6 SUGCT SYNE2 SLC3A1	3.95e-04	185	83	4	1bbc2ba8a20f72f61981b1301cdd6018cdd9150d
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MACF1 DOCK6 UTRN FILIP1L	4.03e-04	186	83	4	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A6 SUGCT PLEKHA7 SLC3A1	4.11e-04	187	83	4	3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5
ToppCell	facs-Lung-EPCAM-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCTE1 IQCA1 CCDC78 MYCBPAP	4.11e-04	187	83	4	051b8c07d7489ce7576f6c57ce7008767ef76869
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	EXOC6 INPP5D SYNE2 UTRN	4.11e-04	187	83	4	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	facs-Lung-EPCAM-18m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCTE1 IQCA1 CCDC78 MYCBPAP	4.11e-04	187	83	4	888856cde7a69ea2f14d590597e25b1af6383c51
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	4.11e-04	187	83	4	1bba994aaaa9825b54aaeaff3829850267bc4602
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	4.11e-04	187	83	4	d6ac351e7aeba98851d308c14ac395044fe4fbbb
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SYNE2 MACF1 UTRN TASOR2	4.19e-04	188	83	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	EXOC6 DOCK6 NOS1 FGF18	4.19e-04	188	83	4	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCTE1 IQCA1 CCDC78 MYCBPAP	4.28e-04	189	83	4	28c750ac56e3861fe7280e32839a4d8ce8bd8692
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCTE1 IQCA1 CCDC78 MYCBPAP	4.28e-04	189	83	4	efee01edd171bf569267b672fab05c421de6c92d
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	4.28e-04	189	83	4	a28e0922e10013ae79266f6a3f9305e6ee614d8b
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|368C / Donor, Lineage, Cell class and subclass (all cells)	NAA35 INPP5D GTPBP10 POLR3A	4.28e-04	189	83	4	610d7cc1fc923dbd67d3b71f94d529a658982f87
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	4.28e-04	189	83	4	fe958fdf9963c2dfe270f67f0da36b3264d0017c
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	4.36e-04	190	83	4	9ffd18ef358f8e32c610ab6420f479067c8ba44b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAP2B SYNE2 MACF1 UTRN	4.36e-04	190	83	4	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	4.36e-04	190	83	4	3ef39d61c98de4e5df946b995847aa65eba6a4b6
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	INPP5D SYNE2 MACF1 UTRN	4.36e-04	190	83	4	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	EXOC6 INPP5D UTRN FGF18	4.36e-04	190	83	4	1519f34d31fe0817184c5865a0bc9f0cb479b1a4
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGEF12 MACF1 UTRN FILIP1L	4.36e-04	190	83	4	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	4.45e-04	191	83	4	649fcb62ad15de2f83e61591e43923a717664ae7
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	4.45e-04	191	83	4	9621e22e14ea069f22713947c9faa2d882abe5fe
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	DDX17 NUP155 MACF1 TYW1	4.45e-04	191	83	4	9454f642c3621370fa23640b631301346b300950
ToppCell	E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCTE1 IQCA1 MDM1 CCDC78	4.45e-04	191	83	4	1e21de183a9c09cfb6aad3f9b948087fb6bad061
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCTE1 IQCA1 CCDC78 MYCBPAP	4.45e-04	191	83	4	6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCTE1 IQCA1 MDM1 CCDC78	4.45e-04	191	83	4	96483adb97c81208aa513782550acd8a08b63866
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	INPP5D SYNE2 DOCK6 UTRN	4.54e-04	192	83	4	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	Control-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	EXOC6 AKR1B1 NOS1 FGF18	4.54e-04	192	83	4	7e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	DDX17 SYNE2 MACF1 PCM1	4.54e-04	192	83	4	47646d7e4990be85072987f92bf18d52f8da752e
Computational	Genes upregulated in subsets of cells of a given type within various tumors	DDX17 SYNE2 MACF1 UTRN	8.14e-05	49	51	4	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	SYNE2 MACF1 PCM1 TASOR2	8.81e-05	50	51	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Neighborhood of IL13	IVL SLC22A6 GLE1 ARHGEF12 RAP2C UTRN ZNF710	1.08e-04	234	51	7	MORF_IL13
Drug	Josamycin [16846-24-5]; Up 200; 4.8uM; HL60; HG-U133A	GLE1 INPP5D CASP2 EHMT1 UTRN PCM1 NPAT	7.03e-06	194	83	7	2034_UP
Drug	(+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA	AEN MDM1 CASP2 PLPBP WDR76 DCP1A ZNF710	7.52e-06	196	83	7	837_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; PC3; HT_HG-U133A	HNF1B RMND5A CASP2 ARHGEF12 PLPBP WDR76 PCM1	8.30e-06	199	83	7	7281_DN
Drug	7-(2-(2-(dimethylamino)ethoxy)ethoxy)-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine	EHMT2 EHMT1	1.31e-05	2	83	2	ctd:C551961
Drug	N-(1-cyclohexylpiperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine	EHMT2 EHMT1	1.31e-05	2	83	2	ctd:C562047
Drug	zinc protoporphyrin	USP13 AP2A1 INPP5D MACF1 RAP2C NOS1	1.52e-05	145	83	6	ctd:C017803
Drug	2-amino-3-(2-amino-2-carboxyethylsulfanyl-mercuricsulfanyl)-propionic acid	SLC22A6 SLC3A1	3.93e-05	3	83	2	ctd:C494607
Drug	Benzbromarone [3562-84-3]; Up 200; 9.4uM; HL60; HT_HG-U133A	AEN GLE1 INPP5D CASP2 UTRN SLC3A1	6.71e-05	189	83	6	1291_UP
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SAMD9 DDX17 RMND5A DOCK6 PCM1 FILIP1L	7.75e-05	194	83	6	4727_DN
Drug	Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; MCF7; HT_HG-U133A	DDX17 CASP2 ARHGEF12 UTRN FGF18 ZNF710	7.75e-05	194	83	6	6090_DN
Drug	UNC0642	EHMT2 EHMT1	7.84e-05	4	83	2	ctd:C000621860
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	HNF1B SAMD9 FAM120C GLE1 CASP2 SLC3A1	7.98e-05	195	83	6	3778_DN
Drug	Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A	RMND5A GLE1 INPP5D ARHGEF12 MACF1 DOCK6	7.98e-05	195	83	6	2394_UP
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	GLE1 CASP2 PLPBP PDCL DOCK6 UTRN	8.44e-05	197	83	6	2128_DN
Drug	rotenone; Up 200; 1uM; MCF7; HT_HG-U133A	IVL DDX17 CASP2 EHMT1 DOCK6 NOS1	8.44e-05	197	83	6	5915_UP
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; HL60; HT_HG-U133A	DDX17 GLE1 CASP2 PDCL RAP2C UTRN	8.44e-05	197	83	6	2354_DN
Drug	Etoposide [33419-42-0]; Up 200; 6.8uM; PC3; HT_HG-U133A	RAP2B FRMPD1 USP29 CASP2 ARHGEF12 ZNF710	8.44e-05	197	83	6	6681_UP
Drug	Ifosfamide [3778-73-2]; Up 200; 15.4uM; MCF7; HT_HG-U133A	SAMD9 APLP1 KDM8 PCM1 SLC3A1 FILIP1L	8.44e-05	197	83	6	3485_UP
Drug	Biotin [58-85-5]; Up 200; 16.4uM; HL60; HT_HG-U133A	HNF1B GLE1 FRMPD1 USP29 CASP2 WDR76	8.44e-05	197	83	6	2428_UP
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A	DDX17 RMND5A CASP2 DOCK6 UTRN SLC3A1	8.68e-05	198	83	6	6046_DN
Drug	Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A	DDX17 SUGCT CASP2 UTRN PCM1 SLC3A1	8.68e-05	198	83	6	5110_DN
Drug	Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; PC3; HT_HG-U133A	APTX ARHGEF12 KDM8 NOS1 PCM1 SLC3A1	8.68e-05	198	83	6	6738_DN
Drug	Nabumetone [42924-53-8]; Up 200; 17.6uM; MCF7; HT_HG-U133A	HNF1B RAP2B RMND5A IQCA1 WDR76 FGF18	8.68e-05	198	83	6	6487_UP
Drug	Practolol [6673-35-4]; Down 200; 15uM; PC3; HT_HG-U133A	HNF1B DDX17 GLE1 CASP2 PDCL UTRN	8.92e-05	199	83	6	4603_DN
Drug	Sulindac [38194-50-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	AEN HNF1B FAM120C ARHGEF12 KDM8 ZNF710	8.92e-05	199	83	6	5103_UP
Drug	Felbinac [5728-52-9]; Down 200; 18.8uM; PC3; HT_HG-U133A	SAMD9 DDX17 GLE1 FRMPD1 FGF18 FILIP1L	9.17e-05	200	83	6	4639_DN
Drug	Ipratropium bromide [22254-24-6]; Down 200; 9.8uM; PC3; HT_HG-U133A	AEN HNF1B ARHGEF12 MACF1 PLPBP PCM1	9.17e-05	200	83	6	5823_DN
Drug	Thimerosal	EXOC6 DNAJC13 SYNE2 TET1 USP29 ASPM EHMT1 ARHGEF12 GNAL DOCK6 PCM1 PHF21A TASOR2 NPAT	1.02e-04	1199	83	14	ctd:D013849
Disease	Kleefstra syndrome 1 (implicated_via_orthology)	EHMT2 EHMT1	7.63e-06	2	82	2	DOID:0060352 (implicated_via_orthology)
Disease	viral infectious disease (implicated_via_orthology)	EHMT2 EHMT1	7.59e-05	5	82	2	DOID:934 (implicated_via_orthology)
Disease	Carcinoma, Ovarian Epithelial	EHMT2 PHF21A STN1	7.96e-05	30	82	3	C4721610
Disease	venous thromboembolism	EIF5AL1 ERCC3 LCA5L EIF5A GNAL FGF18 PHF21A	2.97e-04	460	82	7	EFO_0004286
Disease	atopic eczema	IVL NAA35 INPP5D MDM1 EHMT1	6.98e-04	252	82	5	EFO_0000274
Disease	phosphatidylcholine measurement	SUGCT SYNE2 MACF1 THSD7B DOCK6	1.19e-03	284	82	5	EFO_0010226
Disease	pancreatic carcinoma	HNF1B IQCA1 SUGCT THSD7B	1.43e-03	174	82	4	EFO_0002618
Disease	heel bone mineral density, urate measurement	YY1AP1 THSD7B UTRN PCM1	1.68e-03	182	82	4	EFO_0004531, EFO_0009270
Disease	HDL cholesterol change measurement	SYNE2 DOCK6	2.02e-03	24	82	2	EFO_0007805
Disease	Uterine leiomyoma	RAP2C STN1 NPAT	2.11e-03	91	82	3	HP_0000131
Disease	nevus count, cutaneous melanoma	SYNE2 STN1 TASOR2	2.11e-03	91	82	3	EFO_0000389, EFO_0004632

Protein segments in the cluster

Peptide	Gene	Start	Entry
NMKNVFAEPQVLHNG	SUGCT	361	Q9HAC7
QHMRKAVPFQVAQKE	AEN	166	Q8WTP8
INIQFPEMKMQRHLN	ANKRD30B	1331	Q9BXX2
QEVKLQPGQVLHMVN	APTX	91	Q7Z2E3
AVDPEKAQQMRFQVH	APLP1	436	P51693
QQEAQKIFKANHPMD	AP2A1	886	O95782
VKLQEAQMQQGPEAH	GLE1	346	Q53GS7
KQQRTPLMEAVVNNH	EHMT2	716	Q96KQ7
NRLNMHNLVEPVNKD	DCP1A	71	Q9NPI6
NQNEPKVLFNHLMGE	DISP1	1456	Q96F81
QKMIEPQRNQVFIFQ	IQCA1	26	Q86XH1
GFQDMNIKKQIQEQH	ASPM	2611	Q8IZT6
NFNHLQVEMILNKPG	AKR1B1	161	P15121
PVLMGEENNVVHNQK	ARHGEF12	191	Q9NZN5
QLMKFENIHTNNKPG	RAVER2	421	Q9HCJ3
NQQSFQDIKPMRDQI	RAP2A	86	P10114
NQQSFQDIKPMRDQI	RAP2B	86	P61225
NQQSFQDIKPMRDQI	RAP2C	86	Q9Y3L5
TQGPNHKMVSQNKER	NPAT	1076	Q14207
HIIRNFQKNPILKQM	TCTE1	86	Q5JU00
HQDPQQNFLVQVMGR	KDM8	321	Q8N371
QQEPMEEIENLKKQH	PCM1	266	Q15154
KGPKTRENQQDVHFM	FGF18	161	O76093
DPEFQHNVGKARMNN	MDM1	651	Q8TC05
HNVGKARMNNLQLPQ	MDM1	656	Q8TC05
MHQQKRQPELVEGNL	MOSPD1	1	Q9UJG1
VHQKLVAQMKQDPQN	PHF21A	16	Q96BD5
FQKEQVDPLQMKLQQ	MACF1	1406	O94854
LPQIMAKHQNEVKNL	LCA5L	196	O95447
THNMDVPNIKRNDFQ	EIF5A	76	P63241
KKQARLVLQPQSNMH	EXOC6	311	Q8TAG9
GHNLTPEEQQMLQQK	MACF1	3841	Q9UPN3
PQQMQQELQRKFHEA	NUP155	756	O75694
QQRQFDIQHKGMNPC	NOS1	1266	P29475
QMRILHVNGFNPEEK	GNAL	61	P38405
VMNINRGNPFQKEVV	GLYATL3	31	Q5SZD4
MPEINTNHLDKQQVQ	IDI1	1	Q13907
THNMDVPNIKRNDFQ	EIF5AL1	76	Q6IS14
QDKFHELMSQLQNPK	GTPBP10	286	A4D1E9
PQHLNVQQLEDMYNK	KCNB1	521	Q14721
MQEANNPRKLQKQIH	CCDC63	141	Q8NA47
QNFEIGHNFARVKMQ	DOCK6	1491	Q96HP0
QGPKNMKHRQQDKDS	FILIP1L	26	Q4L180
HMKRNQNLLEPRQKQ	FRMPD1	361	Q5SYB0
YLPMNNREKNHLQEQ	FAM120C	1071	Q9NX05
DHRFQVQPKNTMNPE	CCDC78	141	A2IDD5
VQPKNTMNPENEQHR	CCDC78	146	A2IDD5
MLEHFKNQQDNPEAN	DNAJC13	1946	O75165
LPKVIQAMNHRNNAI	DNAJC13	2051	O75165
NQAINPKLMQLVDHR	DDX17	541	Q92841
QGERMQILQNFKHNP	ERCC3	586	P19447
RQQQEHQKYMVPLQA	SLC22A6	541	Q4U2R8
GIDPNFKMEHQNKRS	EHMT1	761	Q9H9B1
MQEKLQNFAQLPAHR	CASP2	251	P42575
EEMRQQLHKGPQFKQ	PDCL	146	Q13371
KGYMQQHNIPQREVV	HNF1B	126	P35680
HIVQKQQTDNPKGMD	UTRN	1501	P46939
DVNLKMPRNNQLLHF	ROGDI	86	Q9GZN7
RIIQQDCQKPNHMEK	STN1	306	Q9H668
QPFALNHQKDIQVLM	RMND5A	221	Q9H871
VEQMFQDPRLSQNKQ	HARS2	281	P49590
DFQQQQVLELKPMEQ	SYNE2	4381	Q8WXH0
PENQQLDQHSEQMKE	SAMD9	1441	Q5K651
EEPNPHMSKQDRNQR	PLEKHA7	101	Q6IQ23
RQMEQYRDQPQHLEK	PLEKHA7	731	Q6IQ23
PGANFIQQRHTQMKR	POLR3A	416	O14802
QLLQQMKNKHSEQPE	INPP5D	386	Q92835
HQFMKEQPDLNFRNP	SLC3A1	276	Q07837
QNEMQKRIPHTINDL	RNASE9	171	P60153
PEQQMGQLKHLEQQE	IVL	306	P07476
HLQKQNVNKLMAVPN	PLPBP	96	O94903
FQQVVKEQLMHQRLP	TET1	1321	Q8NFU7
KHFQQAKMILENIPN	NAA35	661	Q5VZE5
DNKEQFMENHNPINS	RWDD4	106	Q6NW29
QSPQNQEMRKHFPQK	STOX1	886	Q6ZVD7
QNHMLKHQNVRPFVC	ZNF710	451	Q8N1W2
NMFLDIIHQNKSQQP	USP29	96	Q9HBJ7
HQPDTFQDLKKNRMQ	MYCBPAP	466	Q8TBZ2
QQQINHIMDPPGKNR	TAMM41	256	Q96BW9
DPAQRKRLQQQMQQH	YY1AP1	161	Q9H869
QQRMNPKQEEHAFES	ZFYVE27	231	Q5T4F4
RPQMKVNEYKENQNI	WDR76	16	Q9H967
ELRKNHKNGPNTENM	TASOR2	1236	Q5VWN6
QPEMILKEAIENHQN	TYW1	441	Q9NV66
SMDQCEQHNLEKPQR	THSD7B	1221	Q9C0I4
QVMKEEHKPQQNGIS	USP13	411	Q92995
IENHQNMIKQFKGVP	TYW1B	386	Q6NUM6
EEEFMKHNSPQQNKN	MYO5C	1461	Q9NQX4